Introduction
Visfatin, an adipocytokine primarily found in visceral fat, plays a crucial role in insulin sensitivity and glucose homeostasis. It exhibits insulin-mimetic effects, stimulating glucose uptake in muscles and adipocytes while suppressing glucose production in the liver. Visfatin achieves this by binding to and activating the insulin receptor, independent of insulin's binding site. This activation triggers downstream signaling pathways, mimicking insulin's actions. However, the complete understanding of how fat tissue contributes to insulin resistance and the precise role of adipocytokines, including visfatin, in the development of type 2 diabetes mellitus (T2DM) requires further investigation.
Description
Recombinant Mouse Visfatin, expressed in E. coli, is a purified protein with a molecular weight of 57 kDa. This non-glycosylated polypeptide chain encompasses amino acids 1-491 of the visfatin sequence, including a 20 amino acid His tag at its N-terminus. Purification is achieved using proprietary chromatographic techniques, resulting in a highly pure (>90%) protein solution.
Physical Appearance
Clear, colorless solution, sterile filtered, at a concentration of 1 mg/ml.
Formulation
The Visfatin protein is supplied in a solution containing phosphate-buffered saline (PBS) at a pH of 7.4.
Stability
For short-term storage (2-4 weeks), store the Visfatin solution at 4°C. For extended storage, freeze the solution at -20°C. To ensure stability during long-term storage, adding a carrier protein like HSA or BSA (0.1%) is recommended. Avoid repeated freeze-thaw cycles to prevent protein degradation.
Purity
The purity of the Visfatin protein is greater than 90% as determined by SDS-PAGE analysis.
Synonyms
PBEF, Pre-B cell colony-enhancing factor, Nicotinamide phosphoribosyltransferase NAmPRTase, Nampt, MGC117256, DKFZP666B131, 1110035O14Rik.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MNAAAEAEFN ILLATDSYKV THYKQYPPNT SKVYSYFECREKKTENSKVR KVKYEETVFY GLQYILNKYL KGKVVTKEKI QEAKEVYREH FQDDVFNERGWNYILEKYDG HLPIEVKAVP EGSVIPRGNV LFTVENTDPE CYWLTNWIET ILVQSWYPITVATNSREQKK ILAKYLLETS GNLDGLEYKL HDFGYRGVSS QETAGIGASA HLVNFKGTDT VAGIALIKKY YGTKDPVPGY SVPAAEHSTI TAWGKDHEKD AFEHIVTQFS SVPVSVVSDS YDIYNACEKI WGEDLRHLIV SRSTEAPLII RPDSGNPLDT VLKVLDILGK KFPVTENSKG YKLLPPYLRV IQGDGVDINT LQEIVEGMKQ KKWSIENVSF GSGGALLQKL TRDLLNCSFK CSYVVTNGLG VNVFKDPVAD PNKRSKKGRL SLHRTPAGNF VTLEEGKGDL EEYGHDLLHTVFKNGKVTKS YSFDEVRKNA QLNIEQDVAP H.